4 Global Firms Withdraw IPO Filing from NASDAQ
Based in Illkirch-Graffenstaden, France, Dynacure SA is a biotech company that develops therapies for neuromuscular diseases. The company declined from going public on July 17, 2021. The company had filed to raise $100 million by offering 6.3 million American depositary share ADSs (equity share of a non-U.S. company) at a price range of $15 to $17. CFO of Dynacure, David Garrett, filed a request with Sec.Gov to treat the withdrawal as confidential. Dynacure SA was founded in 2016, and since then, it has participated in funding raising in total $110 million. The last round took place in April 2020 for a total of $55 million.
Company Name
Shares
Date Filed
Offer Amount
Date Withdrawn
DYNACURE S.A.
6,250,000
6/25/2021
$122,187,500.00
7/19/2021
DoubleDown Interactive Co., Ltd.
5,500,00...